» Articles » PMID: 8648701

Quantitative Model of Antibody- and Soluble CD4-mediated Neutralization of Primary Isolates and T-cell Line-adapted Strains of Human Immunodeficiency Virus Type 1

Overview
Journal J Virol
Date 1996 Jun 1
PMID 8648701
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Primary isolates (PI) of human immunodeficiency virus type 1 (HIV-1) are considerably less sensitive than T-cell line-adapted strains to neutralization by soluble CD4 and by most cross-reactive monoclonal antibodies to the viral envelope (Env) glycoprotein, as well as by postinfection and postvaccination sera (J. P. Moore and D. D. Ho, AIDS 9 [suppl. A]:5117-5136, 1995). We developed a quantitative model to explain the neutralization resistance of PI. The factors incorporated into the model are the dissociation constants for the binding of the neutralizing agent to native Env oligomers, the number of outer Env molecules on the viral surface (which decreases by shedding), and the minimum number of Env molecules required for attachment and fusion. We conclude that modest differences in all these factors can, when combined, explain a relative neutralization resistance of PI versus T-cell line-adapted strains that sometimes amounts to several orders of magnitude. The hypothesis that neutralization of HIV is due to the reduction below a minimum number of the Env molecules on a virion available for attachment and fusion is at odds with single- and few-hit neutralization theories. Our analysis of these ideas favors the hypothesis that neutralization of HIV is instead a competitive blocking of interactions with cellular factors, including adsorption receptors.

Citing Articles

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.

Ringe R, Colin P, Ozorowski G, Allen J, Yasmeen A, Seabright G PLoS Pathog. 2023; 19(10):e1011601.

PMID: 37903160 PMC: 10635575. DOI: 10.1371/journal.ppat.1011601.


Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.

Ringe R, Pugach P, Cottrell C, LaBranche C, Seabright G, Ketas T J Virol. 2018; 93(4).

PMID: 30487280 PMC: 6363999. DOI: 10.1128/JVI.01656-18.


Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.

Brandenberg O, Magnus C, Rusert P, Gunthard H, Regoes R, Trkola A PLoS Pathog. 2017; 13(5):e1006313.

PMID: 28472201 PMC: 5417720. DOI: 10.1371/journal.ppat.1006313.


Dense Array of Spikes on HIV-1 Virion Particles.

Stano A, Leaman D, Kim A, Zhang L, Autin L, Ingale J J Virol. 2017; 91(14).

PMID: 28446665 PMC: 5487557. DOI: 10.1128/JVI.00415-17.


Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions.

Song Q, Stone S, Drebes D, Greiner L, Dvorak C, Murtaugh M Virus Res. 2016; 226:85-92.

PMID: 27287711 PMC: 7126973. DOI: 10.1016/j.virusres.2016.06.002.


References
1.
Moore J, Cao Y, Qing L, Sattentau Q, Pyati J, Koduri R . Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol. 1995; 69(1):101-9. PMC: 188553. DOI: 10.1128/JVI.69.1.101-109.1995. View

2.
Ashkenazi A, Smith D, Marsters S, Riddle L, Gregory T, Ho D . Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc Natl Acad Sci U S A. 1991; 88(16):7056-60. PMC: 52232. DOI: 10.1073/pnas.88.16.7056. View

3.
Groenink M, Moore J, Broersen S, Schuitemaker H . Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment. J Virol. 1995; 69(1):523-7. PMC: 188603. DOI: 10.1128/JVI.69.1.523-527.1995. View

4.
Klasse P, McKeating J . Soluble CD4 and CD4 immunoglobulin-selected HIV-1 variants: a phenotypic characterization. AIDS Res Hum Retroviruses. 1993; 9(7):595-604. DOI: 10.1089/aid.1993.9.595. View

5.
DULBECCO R, Vogt M, Strickland A . A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology. 1956; 2(2):162-205. DOI: 10.1016/0042-6822(56)90017-4. View